Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000097.xml
Deutsche Zeitschrift für Onkologie 2022; 54(02): 92-94
DOI: 10.1055/a-1828-4029
DOI: 10.1055/a-1828-4029
Forum – GfBK kommentiert
Der beste Tageszeitpunkt für Checkpoint-Inhibitoren
Qian DC, Kleber T, Brammer B et al. Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): A propensity score-matched analysis of a single-centre, longitudinal study. Lancet Oncol 2021; 22: 1777–1786. doi:10.1016/S1470-2045(21)00546-5
Publication History
Article published online:
29 June 2022
© 2022. Thieme. All rights reserved.
Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart,
Germany